Monkeys developed protective antibodies to SARS-CoV-2
On Mar. 17, 2020, a small study of macaques found they don’t develop a coronavirus infection the second…
Regeneron announced important advances in novel COVID-19 antibody program
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…
Vir Biotec announced intent to collaborate with Biogen on manufacturing of antibodies to potentially treat COVID-19
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
AbCellera and Eli Lilly to co-develop antibody therapies for treatment of COVID-19
On Mar. 12, 2020, AbCellera and Eli Lilly announced an agreement to co-develop antibody products for the treatment…
Chembio and LumiraDx announced COVID-19 strategic partnership
On Mar. 12, 2020, Chembio Diagnostics announced it has entered into a worldwide strategic partnership with LumiraDx Limited…
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
ImmunityBio announced durable virus control of SHIV without anti-retroviral therapy
On Mar. 10, 2020, ImmunityBio announced results from studies evaluating N-803, an IL-15 superagonist, alone and in combination…
Mount Sinai and Harbour BioMed collaborated to advance treatment of cancer and Coronavirus COVID-19
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
Vir Biotec and WuXi Biologics announced collaboration for global development of antibodies to treat COVID-19
On Feb. 25, 2020, Vir Biotech announced a development and manufacturing collaboration to advance and produce human monoclonal…
Artificial Intelligence | Biotechnology | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Artificial intelligence yielded new antibiotic
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
Vir Biotec identified two antibodies that bind to spike protein of SARS-CoV-2
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
AbCellera mobilized response to the novel coronavirus outbreak as part of its DARPA P3 program
On Jan. 28, 2020, AbCellera confirmed that it had mobilized its pandemic response platform against the ongoing outbreak…
Vir Biotec applying multiple platforms to address public health risk from coronavirus
On Jan. 22, 2020, Vir Biotech announced it was working to rapidly determine whether its previously identified anti-coronavirus…
Lack of new antibiotics threatens global efforts to contain drug-resistant infections
On Jan. 17, 2020, the World Health Organization (WHO) reported that declining private investment and lack of innovation…
Researchers at Vanderbilt University Medical Center isolated an antibody that blocks bird flu
On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…
Chembio Diagnostics received WHO prequalification approval for HIV Self-Test
On Nov. 4, 2019, Chembio Diagnostics announced its SURE CHECK HIV Self-Test has received World Health Organization (WHO)…
IRBM signed agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
Chembio Diagnostics received CE Mark for point-of-care multiplex test for Zika, Dengue and Chikungunya
On Jun. 27, 2019, Chembio Diagnostics announced that is had obtained a CE mark for its DPP Zika/Dengue/Chikungunya…
FDA authorized marketing of first diagnostic test for detecting Zika virus antibodies
On May 23, 2019, the U.S. Food and Drug Administration (FDA) announced that it had authorized InBios’ marketing…
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
Diagnostics | Disease | FDA
InBios received FDA clearance for its DENV detect NS1 ELISA test for early detection of Dengue fever
On Sept. 11, 2018, the U.S. Food and Drug Administration (FDA) had announced that it had received 510k…
InBios received FDA EUA for its ZIKV Detect IgM Capture ELISA diagnostic test for antibodies in human serum
On Aug. 19, 2016, InBios announced that it had received an Emergency Use Authorization (EUA) from the U.S….
InBios received USDA license for its West Nile Virus antibody detection kit for horses
On Jan. 24, 2014, InBios announced that it had licensed a U.S. Department of Agriculture (USDA) West Nile…
Biotechnology | Diagnostics | Disease | Life Science News | Medical Device | Medicine | Pharmaceutical | Therapeutics
Sanford Health acquired Hematech
On Jan. 4, 2013, Sanford Health announced the acquisition of Sioux Falls-based biotech company Hematech, a subsidiary of…
Drs. Judith James and John Harley at the OMRF published an important study that showed certain antibodies for lupus were typically present years before the disease with diagnosed
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
Aptein was acquired by Cambridge Antibody Technology
On Jul. 15, 1998, Aptein, founded by Glenn Kawasaki in Seattle, was acquired by Cambridge Antibody Technology (CAT)…
Hematech relocated to Sioux Falls
In 1998, Hematech was co-founded by University of Massachusetts researcher Jim Robl, relocated to Sioux Falls. Dr. Robl…
Diagnostics | FDA | HIV | Life Science News
The FDA approved the first test for HIV antigen screening of blood donors
On Mar. 14, 1996, the U.S. Food and Drug Administration (FDA) announced the approval of the first antigen…
Gene therapy, immune-system modulation and recombinantly produced antibodies entered the clinic in the war against cancer
In 1995, Gene therapy, immune-system modulation and recombinantly produced antibodies enter the clinic in the war against cancer.
The FDA approved the first US HIV test system using oral fluid samples
On Dec. 23, 1994, the FDA announced the approval of the first U.S. HIV test system using oral…